Login to Your Account



Grandhope, PKU build regenerative medicine institute, $48M VC fund

By Cornelia Zou
Staff Writer

Wednesday, July 16, 2014

HONG KONG – A Guangzhou-based biotech company is working with one of the most prestigious universities in China to build a new institute and raise a fund to drive the development of stem cell and regenerative medicine projects.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription